NUCALA® Mepolizumab 100 mg/mL Injection - Prefilled Auto-Injector for Asthma & EGPA
USAMP#20470758SKU: 00173089201NUCALA®
License Required
Product Spotlight
- NUCALA® (Mepolizumab) is a targeted therapy designed as an add-on maintenance treatment for patients 6 years and older with severe eosinophilic asthma, offering improved breathing and reduced asthma attacks.
- Effective for adults with eosinophilic granulomatosis with polyangiitis (EGPA), NUCALA® helps control symptoms by blocking interleukin-5 (IL-5), reducing eosinophil levels in the blood.
- Administered via a convenient prefilled auto-injector, NUCALA® offers a precise 100 mg/mL dose designed for easy, self-administration.
- Manufactured by Glaxo Specialty, NUCALA® is a leading IL-5 antagonist monoclonal antibody treatment, offering hope and improved quality of life for patients with eosinophilic asthma and EGPA.
